Preparation method and use method of 118-site tyrosine phosphorylated MLC2 antibody
Through Abdesigner software analysis and peptide coupling technology, a tyrosine phosphorylated MLC2 antibody with high phosphorylation specificity and affinity was prepared, which solved the problem of insufficient phosphorylation specificity and affinity of existing antibodies and improved protein Accuracy and experimental efficiency of phosphorylation detection.
Patent Information
- Application Number
- CN202411300892.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
During the preparation of existing phosphorylated antibodies, it is difficult to obtain antibodies with higher phosphorylation specificity and better affinity, which affects the accuracy and efficiency of protein phosphorylation detection and signaling pathway research.
Abdesigner software was used to analyze the amino acid sequence of MLC2 protein, determine specific antigen epitope polypeptide sequences, and improve the phosphorylation specificity and affinity of the antibody for cellular immunofluorescence and immunity. Hermetic chemistry experiment.
The prepared tyrosine phosphorylated MLC2 antibody has high phosphorylation specificity and affinity, and can recognize the phosphorylation state of tyrosine at 118 MLC2. It is suitable for large-scale output and improves protein phosphorylation detection. accuracy and experimental efficiency.
Smart Images

Figure CN119039433A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and specifically relates to a preparation method and a use method of an antibody against tyrosine phosphorylated MLC2 at position 118. Background Art
[0002] Phosphoantibodies are widely used in the field of cell signal transduction. They can specifically recognize protein phosphorylation modifications and are used to detect and study different signaling pathways.
[0003] The preparation of phosphorylated antigens requires first determining the phosphorylation position of the protein of interest, such as serine, threonine, and tyrosine. Phosphorylated antigens can be obtained by synthesizing peptides through recombinant proteins or chemically modifying natural proteins. The most common method is peptide synthesis; the specific process is as follows
[0004] 1. Confirm the peptide sequence and design primers based on the desired phosphorylation site
[0005] Prepare peptide chains through synthetic mechanisms. After synthesis, mass spectrometry HPLC and other detection methods are required to confirm the structure and purity of the synthetic peptides. Use phosphorylase to phosphorylate the peptides at the desired sites or use other methods such as photochemistry or artificial synthesis to perform phosphorylation modification. Finally, the purity and activity of the phosphorylated antigens are detected and preserved.
[0006] The preparation of phosphorylated antibodies is similar to that of traditional antibodies, and both use animal immunization technology to prepare antibodies. The specific steps are as follows:
[0007] 1. Inject the phosphorylated antigen into mice and other animals. In order to enhance the immune effect, it can be mixed with adjuvants or antigen vaccines for immunization. After multiple inductions, specific antibodies are produced in the mice.
[0008] 2. Remove the spleen of the mouse to prepare spleen cells fused with Myloma cells, establish an exchange cell bank through cell fusion technology, screen and separate specific phosphorylated antibodies, and obtain specific phosphorylated antibodies through the above antibody screening process. Purification and detection.
[0009] 3. The final prepared phospho-antibody can be stored in fully functional conditions for further experimental applications.
[0010] Phosphorylation antibody significance
[0011] 1. Phosphorylation antibodies can be used to detect the activity modification of protein kinases. For example, in the protein immunoblotting experiment of phosphorylation antibodies, the activity of protein kinases can be reflected by comparing the recognition of non-phosphorylated antibodies and phosphorylated antibodies on the same protein.
[0012] 2. Phosphorylation antibodies can be used to detect the activation status of signal pathways. For example, in protein chip experiments, phosphorylation antibodies can be uploaded to detect protein phosphorylation. Through these studies, we can fully understand the relationship between protein phosphorylation and the signal pathways in which it participates. Through these studies, we can fully understand the relationship between the signal pathways in which protein phosphorylation is expected to participate.
[0013] 3. Phosphorylated antibodies can be used in the study of cell apoptosis, for example, to investigate the degree to which compounds such as paclitaxel induce cell apoptosis.
[0014] Phosphorylation antibody cell signal transduction is a powerful and widely used tool, and it is a field worth exploring for biological researchers. Its preparation requires multiple immunizations and a rigorous screening process, and can be used to study various unidirectional or bidirectional transduction pathways, providing a very important experimental means for cell signal transduction research. At present, how to obtain antibodies with higher phosphorylation specificity and better affinity is the best way to improve detection capabilities and quality. Summary of the invention
[0015] The purpose of the present invention is to provide a method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 with high phosphorylation specificity and high affinity.
[0016] In order to solve the above technical problems, the present invention discloses a method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118, comprising the preparation of an antigen, immunization, preparation of an affinity chromatography column and preparation of an antibody, wherein the antibody against tyrosine phosphorylated MLC2 at position 118 is used for cell immunofluorescence and immunohistochemistry experiments, and is characterized in that the amino acid sequence of the MLC2 protein is subjected to antigen epitope analysis using Abdesigner software, wherein the analysis content includes the evaluation of multiple indexes including hydrophilicity, antigenicity, surface possibility and flexible area, and multiple factors including the complexity of the amino acid structure, the degree of oxidation, the difficulty of synthesis, the category and distribution of amino acids are considered at the same time, and the sequence of MLC2 is first determined to be KRAGGANS(p)NVFSM; in order to ensure the subsequent polypeptide cross-linking carrier protein and peptide affinity purification, a cysteine C is added to the C-terminus of the polypeptide chain, so that the polypeptide is coupled to KLH through cysteine, and finally the MLC2 antigen epitope polypeptide sequence is determined to be KRAGGANS(p)NVFSMC;
[0017] In the method for preparing the antibody against tyrosine phosphorylated MLC2 at position 118, the immunization part comprises at least the following steps:
[0018] a. Immunization method
[0019] a1. Basic immunization: Take the sheep to be immunized out of the cage and place it on the operating table. Subcutaneously inject 8-10 parts of the sheep, injecting 0.3-0.5ml of qualified emulsified antigen into each part;
[0020] a2. Enhanced immunization: In addition to the 5 subcutaneous immunization points on the back, two additional muscle sites are injected, with 0.1-0.3 ml of antigen injected at each site;
[0021] a3. Serum collection: Collect blood for testing twice, collect test blood A on the seventh day after the first booster immunization, and collect test blood B seven days after the second booster immunization; collect positive blood seven days after the third booster immunization and keep the sample as test serum;
[0022] a4. Centrifuge the collected test blood A and test blood B to separate the serum.
[0023] The preparation of the antigen comprises the following steps:
[0024] b. Peptide coupling
[0025] b1. Add Sulfo-SMCC to the KLH solution to obtain a KLH-SMCC solution, remove free Sulfo-SMCC from the KLH-SMCC solution using a desalting column; balance the desalting column with at least 3 column volumes of cross-linking buffer, and then load the sample; after the KLH-SMCC solution enters the gel bed, elute with the cross-linking buffer; collect the protein peak where the KLH-SMCC is located by measuring the light absorption value at 280nm and collect the peak liquid; combine each peak liquid;
[0026] b2. The concentration of KLH-SMCC was collected by Lowry method, and KLH-SMCC was packaged at 3 mg / tube according to the measured protein concentration;
[0027] b3. Add 20 mg / ml polypeptide solution and react for at least 6 hours, then add L-cysteine solution and react for several hours;
[0028] b4. The mixture was transferred to a newly treated dialysis bag and dialyzed with PBS buffer. After the dialysis was completed, all the contents of the dialysis bag were collected and the dialysis bag was flushed with PBS buffer at 38°C-45°C under pressure, and all the flushing fluid was collected;
[0029] b5. Dilute the polypeptide-KLH conjugate to 1 mg / ml and package it to obtain polypeptide-KLH antigen, and store it at low temperature.
[0030] The preparation method of the emulsified antigen in a1 is as follows:
[0031] c. Antigen emulsification
[0032] c1. Before immunization, the double syringe required for antigen emulsification and the glass syringe for immunization should be prepared in advance according to the plan and labeled;
[0033] c2. On the day of immunization, according to the plan, take out the polypeptide-KLH antigen and the corresponding Freund's adjuvant;
[0034] c3. Dilute the antigen to 1 ml / sheep with 0.01 M PBS;
[0035] c4. Absorb all the antigens into one emulsification syringe, and use another syringe to absorb a volume of Freund's adjuvant equal to the antigen liquid. Expel the gas in the syringes, connect the two syringes with a double needle, push the antigen liquid into the adjuvant quickly and forcefully, and then push and pull the double syringe repeatedly until the emulsification is completed; transfer the antigen that has passed the emulsification test into the glass syringe for injection through the double needle, and install the needle for standby use.
[0036] The preparation of the affinity chromatography column comprises the following steps:
[0037] d. Preparation of affinity chromatography column
[0038] d1. Coupling of peptide and Sulfolink Gel: Take out Sulfolink Gel from 4℃ refrigerator and let it reach room temperature; put the column vertically and open the top cover; wash the column with one column volume of cross-linking buffer, leave a small amount of cross-linking buffer at the bottom of the column, and install the bottom disc gel fixing piece;
[0039] d2. Take the mixed suspension of Sulfolink Gel and load it into the chromatography column, balance it with at least 20 ml of cross-linking buffer, and then install the bottom cover of the chromatography column;
[0040] d3. Dilute the dissolved 2 mg peptide into 2 ml cross-linking buffer;
[0041] d4. Add the polypeptide solution to the chromatography column, which is a Sulfolink Gel chromatography column. Shake and mix the chromatography column at 4°C overnight. The next day, let the chromatography column stand at room temperature for tens of minutes. Remove the top and bottom covers of the chromatography column in the order of top first and bottom later, and drain and collect the polypeptide solution after the reaction in the chromatography column.
[0042] d5. Block the non-specific sites on the Sulfolink Gel: reopen the bottom cover of the chromatography column, take 2 ml of 50 mM L-cysteine solution and add it to the column to react with the gel, install the top cover of the chromatography column, mix and react at room temperature for several hours; let it stand at room temperature for dozens of minutes, and release the excess L-cysteine solution;
[0043] d6. Wash the column: remove the top cover and bottom cover of the column in the order of top first and bottom later, drain the liquid in the column, wash the column with PBS, install the disc glue fixing piece on the top of the column in the first wash, and then wash the column with 1 mol / L NaCl solution, PBS buffer, and Gly-HCl buffer respectively to obtain an affinity chromatography column;
[0044] d7. Storage of affinity chromatography column: Reinstall the bottom cover, add 10 ml of storage solution to the column, allow it to flow out until the upper liquid surface is 0.8±0.2 cm away from the disc gel fixed surface, and then reinstall the top cover to obtain the affinity chromatography column.
[0045] The preparation of the antibody comprises the following steps:
[0046] e. Serum treatment: Take out each batch of serum to be treated, mix them, add 1 / 10 volume of 1 mol / L Tris PH7.5 buffer to adjust the pH value according to the amount of serum, mix well at room temperature, let stand for a period of time, and then filter with a sterilization membrane;
[0047] f. P-peptide column chromatography coupled with phosphorylated peptide;
[0048] f1. Take out the affinity chromatography column that has been cross-linked and coupled with phosphorylated polypeptide from the 4°C refrigerator, place it at room temperature, and remove the top cover first to prevent air from entering the gel bed;
[0049] f2. Remove the bottom cover and let the excess storage buffer flow out; wash the column with 10mM PBS pH7.420ml;
[0050] f3. Take out 2 ml of P-peptide-coupled Sulfolink Gel from the column, mix it with the treated serum sample, rotate the mixed sample on a silent rotator, and mix and react overnight at 4°C or at room temperature for 2 hours;
[0051] f4. Place the empty chromatography column upright on the chromatography rack, add 10 ml PBS and use an ear-cleaning bulb to remove the air on the chromatography column film and under the film; gradually load the serum-Sulfolink Gel mixed solution into the chromatography column, and the Sulfolink Gel will settle to form a gel bed. Wash the chromatography column with 5-7 ml PBS to wash out the serum contained in the gel, and collect the effluent;
[0052] f5. Wash the column with 20ml 10mM PBS (pH7.4). When the liquid level is 1-2cm away from the gel surface, plug the bottom cover of the column, install the disc film on the gel, and then wash the column with 10ml PBS pH7.4. Finally, wash the column with 20ml 10mM PBS pH7.4 containing 0.05% Tween20 solution.
[0053] f6. Prepare two 1.5ml collection tubes containing 100ul 1M Tris·HCl PH7.5 and a 30ml bottle for each sample and label them;
[0054] f7. Wash the column with 100mM glycine buffer PH3.01ml first, without collecting the eluate, and then wash the column twice with 100mM glycine buffer PH3.01ml, collecting the effluent each time in a 1.5ml centrifuge tube, mixing it to restore the pH to neutral, and then decide whether to collect it in a bottle or a colorimetric cup according to the amount of protein, until no protein is collected;
[0055] f8. Compare the collected solution in each tube at 280nm, and combine the solution with light absorption exceeding 0.1 into the eluent for the next purification step;
[0056] f9. Repeat the steps f1-f8 for the serum effluent after the peptide chromatography until the antibody is completely absorbed;
[0057] f10. If the sample concentration is too high and a precipitate is produced, centrifuge to remove the precipitate; measure the absorbance of the final eluate;
[0058] f11. Keep a sample of purified serum for ELISA detection.
[0059] In c2, complete Freund's adjuvant is used for the primary immunization, and incomplete Freund's adjuvant is used for the booster immunization.
[0060] In c4, before transfer, it is necessary to check whether the label numbers of the emulsification syringe, injection syringe and needle are consistent.
[0061] The KLH-SMCC solution was prepared according to KLH 100 mg: water 12.5 ml: Sulfo-SMCC 25 mg.
[0062] In c3, 0.3-0.4 ml of whole blood was collected from each sheep each time.
[0063] A method for using an antibody against tyrosine phosphorylated MLC2 at position 118, characterized in that the phosphorylation specificity of the antibody is detected by the ELSIA method, and recognition and comparison are performed after the antibody is coated with phosphorylated MLC2 Tyr118 polypeptide and non-phosphorylated MLC2 polypeptide respectively.
[0064] The method for preparing the antibody of MLC2 phosphorylated at position 118 of the present invention is suitable for large-scale production of the antibody of MLC2 phosphorylated at position 118. The antibody can recognize the phosphorylated state of tyrosine at position 118 of MLC2, but not the non-phosphorylated state, and has the characteristics of high phosphorylation specificity and good affinity. BRIEF DESCRIPTION OF THE DRAWINGS
[0065] Figure 1 The results were verified by immunofluorescence. DETAILED DESCRIPTION
[0066] The present invention is further described in detail below through examples so that those skilled in the art can implement the invention with reference to the description.
[0067] It should be understood that the terms such as “having”, “including” and “comprising” used herein do not exclude the existence or addition of one or more other elements or combinations thereof.
[0068] 1 Antigen design
[0069] Abdesigner software was used to analyze the antigen epitope of the amino acid sequence of MLC2 protein, mainly evaluating the hydrophilicity, antigenicity, surface possibility, flexible area and other indexes. Combined with the actual experience of preparing antibodies in the past, the complexity of the amino acid structure, the degree of oxidation, the difficulty of synthesis, the type and distribution of amino acids were considered, and the sequence of MLC was finally determined to be KRAGGANS(p)NVFSM. At the same time, in order to ensure the later peptide cross-linking carrier protein and peptide affinity purification, a cysteine C was added to the C-terminus. The final peptide sequence to be synthesized is KRAGGANS(p)NVFSMC
[0070] 2. Peptide coupling
[0071] (1) KLH dissolution: Dissolve KLH in degassed pure water according to the proportions in the table below.
[0072]
[0073]
[0074] (2) Add SMCC: Weigh Sulfo-SMCC according to the proportion in the table below and add KLH solution. (Note: The solubility of Sulfo-SMCC in water or other commonly used buffers is about 10 mM, and its solubility decreases with increasing salt concentration.
[0075]
[0076] (3) Reaction: The KLH-Sulfo-SMCC solution was slowly stirred at room temperature for 60 minutes.
[0077] (4) Desalting: Use a desalting column to remove free Sulfo-SMCC from the KLH-Sulfo-SMCC solution. Equilibrate the desalting column with 3 column volumes of cross-linking buffer, then load the sample. If the volume is large, load the sample several times. After the KLH-SMCC solution enters the gel bed, elute it with the cross-linking buffer. Collect the protein peak where KLH-SMCC is located by measuring the light absorbance at 280nm and collect this peak liquid, and combine each peak liquid. (Note: The cross-linking agent can react with the desalting column, so this desalting column can only be used to remove free SMCC.)
[0078] (5) Determination: The concentration of KLH-SMCC was determined by the Lowry method.
[0079] (6) Packaging: Pack KLH-SMCC at 3 mg / tube according to the measured protein concentration.
[0080] Weigh the desired polypeptide (the weight ratio of polypeptide to KLH is 1:1).
[0081] (7) Dissolve the polypeptide in sterile and degassed pure water to a final concentration of 20 mg / ml. If it is difficult to completely dissolve the polypeptide after dissolution, dissolution aid can be used.
[0082] (8) Mix KLH-SMCC and the peptide solution.
[0083] (9) The mixture was reacted in a silent mixer at 4°C overnight.
[0084] (10) L-cysteine was weighed for blocking, and the weight ratio of cysteine to KLH was 2:1.
[0085] (11) Add an appropriate amount of water to dissolve cysteine, and add the dissolved cysteine solution to the polypeptide-KLH mixture.
[0086] (12) The mixture was gently shaken at 4°C for 2 hours.
[0087] (13) After blocking, the mixed solution was transferred to a newly treated dialysis bag and dialyzed with 0.01 M PBS. The dialysis solution was replaced at least twice, with an interval of no less than 4 hours between each change.
[0088] (14) After dialysis is completed, collect all the contents in the dialysis bag, especially the precipitate that may be formed during dialysis. This part of the precipitate is usually the best immunogen. The precipitate produced during the dialysis process has a certain degree of adhesion and may adhere to the inner wall of the dialysis bag. It is not easy to completely rinse this part of high-quality immunogen with only one or two simple rinses with room temperature 0.01M PBS. Therefore, the PBS is appropriately heated, and then the PBS is sucked into a syringe with a long needle. The syringe is pushed to make the needle spray out PBS with a certain pressure, and the inner wall of the dialysis bag is rinsed from bottom to top for no less than 2 times to achieve a better precipitation elution and collection effect. Collect all the rinse fluid and let it dry to room temperature.
[0089] (15) According to experience, the theoretical coupling rate of peptides and KLH is about 30%, which is applicable to most peptides. For example, 10 mg of KLH is coupled with 10 mg of peptide, and the theoretical amount of the peptide-KLH conjugate obtained is 13 mg. Based on the theoretical yield, the peptide-KLH conjugate is diluted to 1 mg / ml.
[0090] (16) Packaging: Pack into 300ug and 200ug portions, label them, and place them in sample boxes.
[0091] (II) Design ideas, methods and functions:
[0092] 1. Rabbit Immunization
[0093] 1. Antigen emulsification
[0094] 1.1 Before immunization, the double syringe required for antigen emulsification and the glass syringe for immunization should be prepared in advance according to the plan and labeled.
[0095] 1.2 On the day of immunization, according to the plan, take out the polypeptide-KLH antigen from the -70℃ refrigerator, and prepare the Freund's adjuvant according to the type of immunization. Use complete Freund's adjuvant for basic immunization and incomplete Freund's adjuvant for booster immunization. This step must be completed by two people and checked one by one.
[0096] 1.3 Dilute the antigen to 1 ml / sheep with 0.01 M PBS.
[0097] 1.4 Absorb all antigens into one emulsification syringe, and absorb an adjuvant of the same volume as the antigen solution into another syringe. The gas in the syringe must be completely expelled. Before aspirating the liquid, a little paraffin oil can be applied to the inner handle of the syringe to reduce the resistance during push and pull emulsification.
[0098] 1.5 Connect the two syringes with a double needle and tighten the needle with tweezers or hemostatic forceps to prevent leakage.
[0099] 1.6 Push the antigen solution into the adjuvant quickly and forcefully (do not push the adjuvant into the antigen solution first), then push and pull the double syringe repeatedly until emulsification is complete. Use moderate force when pushing and pulling to avoid the double needle from breaking open.
[0100] 1.7 Fill a clean dish with cold water and drop a small drop of the emulsified antigen-adjuvant mixture into the water. If there is no diffusion of the droplet, the emulsification is successful. If there is diffusion, continue to push and pull the emulsification until the emulsification is successful.
[0101] 1.8 Transfer the emulsified antigens that have passed the test into the glass syringe for injection through the double needle, and install the needle for standby use. Before transfer, check whether the label numbers of the emulsification syringe, injection syringe and needle are consistent.
[0102] 2. Basic immunity
[0103] 2.1 Take the sheep to be immunized out of the cage and place it on the operating table. Grab the sheep according to the prescribed method and be gentle. If necessary, gently touch the sheep with your hands. Wait until it is quiet before grabbing or performing other operations. Try to avoid frightening the sheep and causing mechanical injuries. The sheep's ear number must be checked when grabbing the sheep.
[0104] 2.2 One person holds the sheep in place, while another person uses curved surgical scissors to shear the wool from front to back on the left side of the back, with a width of 1-2 cm.
[0105] 2.3 Use 75% alcohol cotton balls to disinfect the skin at the hair cutting site.
[0106] 2.4 Check whether the syringe label number is consistent with the sheep ear number, and then start immunization. Basic immunization is subcutaneous injection at 8-10 sites, with 0.3-0.5ml of antigen at each site.
[0107] 3. Strengthen immunity
[0108] 3.1 Carry out booster immunization according to the company's plan. The basic operations and precautions for booster immunization are the same as those for basic immunization.
[0109] 3.2 The first booster immunization should be carried out by shearing the wool on the right side of the sheep's back. Remember not to inoculate the antigen into the basic immune ulcer or granuloma. This should also be noted in subsequent booster immunizations.
[0110] 3.3 In addition to the 5 subcutaneous immunization points on the back, two additional muscle sites were injected. Disinfect the inner skin of the two hind thighs of the sheep with alcohol cotton, then insert the needle into the muscle and inject 0.1-0.3ml of antigen at each site.
[0111] 4. Serum Collection
[0112] 4.1 Blood for testing is generally collected twice, that is, test blood A is collected on the seventh day after the first booster immunization, and test blood B is collected on the seventh day after the second booster immunization. Seven days after the third booster immunization, positive blood is collected and retained as test serum.
[0113] 4.2 Before blood collection, the blood collection tubes should be prepared in advance according to the plan and clearly marked. This step must be reviewed by someone.
[0114] 4.3 Test serum is divided into one tube for each sheep according to the sheep number.
[0115] 4.4 Take the sheep that needs blood collection out of the cage and fix it on the sheep holder. Grab the sheep according to the prescribed method and be gentle. If necessary, gently touch the sheep with your hands. Wait until it is quiet before grabbing or performing other operations. Try to avoid frightening the sheep and causing mechanical injuries. When grabbing the sheep, you must check whether the blood collection tube number and the sheep ear number are consistent.
[0116] 4.5 Cut off the hair around the sheep's ear, wipe the auricle with an alcohol cotton ball, and tap the veins with your fingernails to make the veins congested and prominent.
[0117] 4.6 Puncture the vein with a disposable syringe needle disinfected with 75% ethanol, and collect whole blood in a 0.5ml centrifuge tube after bleeding. Collect about 0.3-0.4ml of whole blood from each sheep.
[0118] 4.7 After blood collection, use alcohol cotton balls to disinfect the wound.
[0119] 4.8 Put the sheep back into the corresponding cage.
[0120] 4.9 The collected whole blood is placed at room temperature for about 1 hour to allow the serum to precipitate.
[0121] 4.10 The whole blood is centrifuged in a palm-type centrifuge to separate the serum. Pay attention to the balance of the centrifuge tube during centrifugation.
[0122] 4.11 Use a pipette to aspirate the serum and transfer it into a sterile 0.5 ml microcentrifuge tube.
[0123] 5. Preparation of affinity chromatography column
[0124] 5.1. Coupling of peptides to Sulfolink Gel
[0125] 5.1.1 Take out the Sulfolink Gel from the 4℃ refrigerator and let it reach room temperature. Place the column vertically and open the top cover. Wash the column with one column volume of cross-linking buffer, leaving a small amount of cross-linking buffer at the bottom of the column and install the bottom disc gel fixing piece.
[0126] 5.1.2 Take the mixed suspension of Sulfolink Gel (the final gel bed volume is 2 ml) and load it into the chromatography column, balance it with at least 20 ml of cross-linking buffer, and then install the bottom cover of the chromatography column.
[0127] 5.1.3 Dilute 2 mg of the dissolved peptide into 2 ml of cross-linking buffer.
[0128] 5.1.4 Add the polypeptide solution to the chromatography column, install the top cover of the chromatography column, and attach a label to the chromatography column.
[0129] 5.1.5 Shake the column to mix well and react overnight at 4°C.
[0130] 5.1.6 The next day, let the chromatography column stand at room temperature for 30 minutes.
[0131] 5.1.7 Remove the top and bottom covers of the chromatography column in the order of top first and bottom later, drain the reacted polypeptide solution in the chromatography column, and collect it in a clean tube.
[0132] 5.1.8 Wash the chromatography column with 20 ml of cross-linking buffer (the amount of cross-linking buffer should be no less than 5 column bed volumes).
[0133] 5.2. Blocking non-specific sites on Sulfolink Gel
[0134] 5.2.1 Reopen the bottom cover of the chromatography column.
[0135] 5.2.2 Take 2 ml of 50 mM L-cysteine solution and add it to the column to react with the gel, and install the chromatography column top cover (the volume ratio of L-cysteine solution to gel is 1:1).
[0136] 5.2.3 Mix and react at room temperature for 2 hours.
[0137] 5.2.4 Let stand at room temperature for 30 minutes.
[0138] 5.2.5 Release the excess cysteine solution.
[0139] 5.3. Column washing
[0140] 5.3.1 Remove the top and bottom covers of the chromatography column in the order of first up and then down, and drain the liquid in the chromatography column.
[0141] 5.3.2 Wash the column with 20 ml PBS and install the upper disc gel fixing piece in the first wash.
[0142] 5.3.3 Then wash the column with 20 ml 1 M NaCl, 20 ml PBS, and 20 ml 100 mM Gly-HCl buffer respectively.
[0143] 5.4. Storage of Peptide Cross-linking Columns
[0144] 5.4.1 Reinstall the bottom cover and add 10 ml of storage solution to the column, allowing it to flow out until the upper liquid surface is about 0.8 cm away from the disc gel fixing surface.
[0145] 5.4.2Reinstall the top cover.
[0146] 6. Affinity Purification
[0147] 1. Materials
[0148] 1. Animal serum
[0149] 2. Peptide cross-linking chromatography column
[0150] 3.1M Tris·HCl, pH 7.5
[0151] 4.100 mM glycine buffer, pH 3.0
[0152] 5.10 mM PBS pH 7.4
[0153] 6.10 mM PBST pH 7.4 (containing 0.05% Tween 20)
[0154] 7. Storage Solution
[0155] Note: All liquids entering the chromatography column must be degassed.
[0156] 2. Operation steps
[0157] 1. Serum Treatment
[0158] 1.1 Take out each batch of serum to be processed and mix them. Control the volume of each reaction to about 40 ml and keep samples for ELISA detection.
[0159] 1.2 According to the amount of serum, add 1 / 10 volume of 1M Tris pH7.5 buffer to adjust the pH value, mix well and let stand at room temperature for 20 minutes.
[0160] 1.3 Filter the pH-adjusted serum sample through a sterilized 0.45 um membrane.
[0161] 2. Peptide column chromatography
[0162] 2.1 Take out the cross-linked P-peptide chromatography column from the 4°C refrigerator and place it at room temperature. First remove the top cover to prevent air from entering the gel bed.
[0163] 2.2 Remove the bottom cover and allow excess storage buffer to flow out. Wash the column with 20 ml of 10 mM PBS pH 7.4.
[0164] 2.3 Take out 2 ml of P-peptide-coupled Sulfolink Gel from the column, mix it with the treated serum sample, rotate the mixed sample on a silent rotator, and mix and react at 4°C overnight or at room temperature for 2 hours.
[0165] 2.4 Place the empty chromatography column upright on the chromatography rack, add 10ml PBS and use an ear-cleaning bulb to remove the air on the chromatography column film and under the film. Add the serum-Sulfolink Gel mixed solution into the chromatography column step by step, and the Sulfolink Gel will be deposited to form a gel bed (to prevent the gel bed from drying up). Wash the chromatography column with 5-7ml PBS (the washed gel contains serum). Collect the outflow in a clean bottle.
[0166] 2.5 Wash the chromatography column with 20ml 10mM PBS pH7.4. When the liquid level is 1-2cm away from the gel surface, plug the bottom cover of the chromatography column, install the disc film on the gel, and then wash the chromatography column with 10ml PBS pH7.4. Finally, wash the chromatography column with 20ml 10mM PBS pH7.4 containing 0.05% Tween20 solution.
[0167] 2.6 Prepare two 1.5ml collection tubes containing 100ul 1M Tris·HCl PH7.5 and a 30ml bottle for each sample and label them.
[0168] 2.7 Wash the column with 100mM glycine buffer PH3.01ml first, without collecting the eluate, and then wash the column twice with 100mM glycine buffer PH3.01ml, collect the effluent each time in a 1.5ml centrifuge tube, mix it to restore the pH to neutral, and then decide whether to collect it in a bottle or a colorimetric cup according to the amount of protein. Finally, collect until there is no protein.
[0169] 2.8 The collected liquid in each tube was colorimetrically compared at 280 nm, and the liquid with light absorption exceeding 0.1 was combined into the eluent for the next purification step.
[0170] The serum effluent after 2.9P peptide chromatography can be repeatedly absorbed according to steps 2.1-2.8 until the antibody is completely absorbed.
[0171] 2.10 If the sample concentration is too high and a precipitate is produced, centrifuge (3000 rpm for 10 minutes) to remove the precipitate. Measure the light absorption of the final eluate.
[0172] 2.11 The purified serum samples were kept for ELISA detection.
[0173] 7ELSIA method was used to detect the phosphorylation specificity of the antibody
[0174] The ELISA values are as follows:
[0175] Phosphorylated MLC2 Tyr118 antibody detection, coated with phosphorylated MLC2 Tyr118 peptide and non-phosphorylated MLC2 peptide
[0176]
[0177] The results of immunofluorescence validation are shown in Figure 1 .
[0178] Although the embodiments of the present invention have been disclosed as above, they are not limited to the applications listed in the specification and the implementation modes. They can be fully applied to various fields suitable for the present invention. For those familiar with the art, additional modifications can be easily implemented. Therefore, without departing from the general concept defined by the claims and the scope of equivalents, the present invention is not limited to the specific details and the embodiments shown and described herein.
Claims
1. A method for preparing an antibody against MLC2 tyrosine phosphorylated at position 118, comprising preparation of an antigen, immunization, preparation of an affinity chromatography column and preparation of an antibody, wherein the antibody against MLC2 tyrosine phosphorylated at position 118 is used in cell immunofluorescence and immunohistochemistry experiments, and is characterized in that: Abdesigner software was used to analyze the antigen epitope of the amino acid sequence of MLC2 protein. The analysis included the evaluation of multiple indexes including hydrophilicity, antigenicity, surface possibility and flexible area. At the same time, multiple factors including the complexity of amino acid structure, oxidation susceptibility, synthesis difficulty, amino acid category and distribution were considered. The sequence of MLC2 was first determined to be KRAGGANS(p)NVFSM. To ensure the subsequent cross-linking of polypeptide carrier protein and peptide affinity purification, a cysteine C was added to the C-terminus of the polypeptide chain to couple the polypeptide with KLH through cysteine. Finally, the MLC2 antigen epitope polypeptide sequence was determined to be KRAGGANS(p)NVFSMC. In the method for preparing the antibody against tyrosine phosphorylated MLC2 at position 118, the immunization part comprises at least the following steps: a. Immunization method a1. Basic immunization: Take the sheep to be immunized out of the cage and place it on the operating table. Subcutaneously inject 8-10 parts of the sheep, injecting 0.3-0.5ml of qualified emulsified antigen into each part; a2. Enhanced immunization: In addition to the 5 subcutaneous immunization points on the back, two additional muscle sites are injected, with 0.1-0.3 ml of antigen injected at each site; a3. Serum collection: Collect blood for testing twice, collect test blood A on the seventh day after the first booster immunization, and collect test blood B seven days after the second booster immunization; collect positive blood seven days after the third booster immunization and keep the sample as test serum; a4. Centrifuge the collected test blood A and test blood B to separate the serum.
2. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 1, characterized in that: The preparation of the antigen comprises the following steps: b. Peptide coupling b1. Sulfo-SMCC was added to the KLH solution to obtain a KLH-SMCC solution, and the KLH-SMCC solution was subjected to a desalting column to remove free Sulfo-SMCC; the desalting column was equilibrated with at least 3 column volumes of cross-linking buffer and then loaded; After the KLH-SMCC solution enters the gel bed, it is eluted with a cross-linking buffer; the protein peak liquid where the KLH-SMCC is located is collected by measuring the light absorption value at 280nm and the peak liquid is collected; each peak liquid is combined; b2. The concentration of KLH-SMCC was collected by Lowry method, and KLH-SMCC was packaged at 3 mg / tube according to the measured protein concentration; b3. Add 20 mg / ml polypeptide solution and react for at least 6 hours, then add L-cysteine solution and react for several hours; b4. The mixture was transferred to a newly treated dialysis bag and dialyzed with PBS buffer. After the dialysis was completed, all the contents of the dialysis bag were collected and the dialysis bag was flushed with PBS buffer at 38°C-45°C under pressure, and all the flushing fluid was collected; b5. Dilute the polypeptide-KLH conjugate to 1 mg / ml and package it to obtain polypeptide-KLH antigen, and store it at low temperature.
3. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 2, characterized in that: The preparation method of the emulsified antigen in a1 is as follows: c. Antigen emulsification c1. Before immunization, the double syringe required for antigen emulsification and the glass syringe for immunization should be prepared in advance according to the plan and labeled; c2. On the day of immunization, according to the plan, take out the polypeptide-KLH antigen and the corresponding Freund's adjuvant; c3. Dilute the antigen to 1 ml / sheep with 0.01 M PBS; c4. Absorb all the antigens into one emulsification syringe, and use another syringe to absorb a volume of Freund's adjuvant equal to the antigen liquid. Expel the gas in the syringes, connect the two syringes with a double needle, push the antigen liquid into the adjuvant quickly and forcefully, and then push and pull the double syringe repeatedly until the emulsification is completed; transfer the antigen that has passed the emulsification test into the glass syringe for injection through the double needle, and install the needle for standby use.
4. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 3, characterized in that: The preparation of the affinity chromatography column comprises the following steps: d. Preparation of affinity chromatography column d1. Coupling of peptide and Sulfolink Gel: Take out Sulfolink Gel from 4℃ refrigerator and let it reach room temperature; put the column vertically and open the top cover; wash the column with one column volume of cross-linking buffer, leave a small amount of cross-linking buffer at the bottom of the column, and install the bottom disc gel fixing piece; d2. Take the mixed suspension of Sulfolink Gel and load it into the chromatography column, balance it with at least 20 ml of cross-linking buffer, and then install the bottom cover of the chromatography column; d3. Dilute the dissolved 2 mg peptide into 2 ml cross-linking buffer; d4. Add the polypeptide solution to the chromatography column, which is a Sulfolink Gel chromatography column. Shake and mix the chromatography column at 4°C overnight. The next day, let the chromatography column stand at room temperature for tens of minutes. Remove the top and bottom covers of the chromatography column in the order of top first and bottom later, and drain and collect the polypeptide solution after the reaction in the chromatography column. d5. Block the non-specific sites on the Sulfolink Gel: reopen the bottom cover of the chromatography column, take 2 ml of 50 mM L-cysteine solution and add it to the column to react with the gel, install the top cover of the chromatography column, mix and react at room temperature for several hours; let it stand at room temperature for dozens of minutes, and release the excess L-cysteine solution; d6. Wash the column: remove the top cover and bottom cover of the column in the order of top first and bottom later, drain the liquid in the column, wash the column with PBS, install the disc glue fixing piece on the top of the column in the first wash, and then wash the column with 1 mol / L NaCl solution, PBS buffer, and Gly-HCl buffer respectively to obtain an affinity chromatography column; d7. Storage of affinity chromatography column: Reinstall the bottom cover, add 10 ml of storage solution to the column, allow it to flow out until the upper liquid surface is 0.8±0.2 cm away from the disc gel fixed surface, and then reinstall the top cover to obtain the affinity chromatography column.
5. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 4, characterized in that: The preparation of the antibody comprises the following steps: e. Serum treatment: Take out each batch of serum to be treated, mix them, add 1 / 10 volume of 1 mol / LTris PH7.5 buffer to adjust the pH value according to the amount of serum, mix well at room temperature, let stand for a period of time, and then filter with a sterilization membrane; f. P-peptide column chromatography coupled with phosphorylated peptide; f1. Take out the affinity chromatography column that has been cross-linked and coupled with phosphorylated polypeptide from the 4°C refrigerator, place it at room temperature, and remove the top cover first to prevent air from entering the gel bed; f2. Remove the bottom cover and let the excess storage buffer flow out; wash the column with 10mM PBS pH7.420ml; f3. Take out 2 ml of P-peptide-coupled Sulfolink Gel from the column, mix it with the treated serum sample, rotate the mixed sample on a silent rotator, and mix and react overnight at 4°C or at room temperature for 2 hours; f4. Place the empty chromatography column upright on the chromatography rack, add 10 ml PBS and use an ear-cleaning bulb to remove the air on the chromatography column film and under the film; gradually load the serum-Sulfolink Gel mixed solution into the chromatography column, and the Sulfolink Gel will settle to form a gel bed. Wash the chromatography column with 5-7 ml PBS to wash out the serum contained in the gel, and collect the effluent; f5. Wash the column with 20ml 10mM PBS (pH7.4). When the liquid level is 1-2cm away from the gel surface, plug the bottom cover of the column, install the disc film on the gel, and then wash the column with 10ml PBS pH7.
4. Finally, wash the column with 20ml 10mM PBS pH7.4 containing 0.05% Tween20 solution. f6. Prepare two 1.5ml collection tubes containing 100ul 1M Tris·HCl PH7.5 and a 30ml bottle for each sample and label them; f7. Wash the column with 100mM glycine buffer PH3.01ml first, without collecting the eluate, and then wash the column twice with 100mM glycine buffer PH3.01ml, collecting the effluent each time in a 1.5ml centrifuge tube, mixing it to restore the pH to neutral, and then decide whether to collect it in a bottle or a colorimetric cup according to the amount of protein, until no protein is collected; f8. Compare the collected solution in each tube at 280nm, and combine the solution with light absorption exceeding 0.1 into the eluent for the next purification step; f9. Repeat the steps f1-f8 for the serum effluent after the peptide chromatography until the antibody is completely absorbed; f10. If the sample concentration is too high and a precipitate is produced, centrifuge to remove the precipitate; measure the absorbance of the final eluate; f11. Keep a sample of purified serum for ELISA detection.
6. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 1, characterized in that: In c2, complete Freund's adjuvant is used for the primary immunization, and incomplete Freund's adjuvant is used for the booster immunization.
7. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 1, characterized in that: In c4, before transfer, it is necessary to check whether the label numbers of the emulsification syringe, injection syringe and needle are consistent.
8. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 1, characterized in that: The KLH-SMCC solution was prepared according to KLH 100 mg: water 12.5 ml: Sulfo-SMCC 25 mg.
9. The method for preparing an antibody against tyrosine phosphorylated MLC2 at position 118 according to claim 3, characterized in that: In c3, 0.3-0.4 ml of whole blood was collected from each sheep each time.
10. A method for using the antibody against MLC2 tyrosine phosphorylated at position 118 according to any one of claims 1 to 9, characterized in that: The phosphorylation specificity of the antibody was detected by ELSIA method, and the recognition was compared after being coated with phosphorylated MLC2 Tyr118 peptide and non-phosphorylated MLC2 peptide.
Citation Information
Patent Citations
Cloning and identification of swine muscle specific MLC2 promoter and application thereof
CN102766629A
Phosphorylated rabbit polyclonal antibody and preparation method and application thereof
CN113788895A
Preparation method and use method of 452 site tyrosine phosphorylated PI3Kp85 antibody
CN116606376A
Preparation method of first / eight-site tyrosine phosphorylated MLC2 antibody for immunohistochemical and immunofluorescence experiments
CN116874579A
Polyclonal antibody of phosphorylating and corresponding non-phosphorylating protein in application for preparing reagent for disease diagnosis, and preparation method
CN1727896A
Cited By
Preparation method of 887th-site serine phosphorylated PLEC antibody
CN120795142A
